|
2024
|
Invention
|
Brawnin agonists for use in the treatment of axonal metabolic disorders. Using primary mouse neur... |
|
2023
|
Invention
|
Intravenous administration of neuroglobin for treating neurological disorders. Using Harlequin (H... |
|
2022
|
Invention
|
Derivatives of nifuroxazide for use in the treatment of mitochondrial disorders and neurodegenera... |
|
|
Invention
|
Method for treating tubular aggregate myopathy and stormorken syndrome. The present invention rel... |
|
2021
|
Invention
|
Method for generating functional skeletal muscle fibers innervated by motoneurons.
The present i... |
|
|
Invention
|
Method for generating functional skeletal muscle fibers innervated by motoneurons. The present in... |
|
2015
|
Invention
|
Method for producing motor neurons from pluripotent cells. The present invention concerns a metho... |
|
2014
|
Invention
|
Combination of an hmg-coa reductase inhibitor and a farnesyl-pyrophosphatase synthase inhibitor f... |
|
2013
|
Invention
|
Combination of an hmg-coa reductase inhibitor and a farnesyl-pyrophosphate synthase inhibitor for... |
|
2007
|
Invention
|
Hmg-coa reductase and farnesyl-pyrophosphate synthase inhibitors for the treatment of conditions ... |
|
2004
|
Invention
|
Myocardium-specific promoter. Myocardium-specific promoter derived from the MYBPC gene of a mamma... |
|
2001
|
Invention
|
Myocardium-specific promoter. The invention concerns a myocardium-specific promoter, derived for ... |
